Sagaliam Acquisition Corp. announced that it has amended the executed non-binding term sheet for the purchase of Biogenysis Inc. ("BGEN") and Virogentics Inc. ("VIRO"), operating subsidiaries of Enzolytics Inc. amending the combined purchase price to $450,000,000. Additionally, the company announce that Ronnie Richardson, Krystine Miller, and Travis Richardson are joining Board of Directors.
Sagaliam Acquisition Corp.
Equities
SAGA
US78661R1068
Investment Holding Companies
1st Jan change | Capi. | |
---|---|---|
+154.80% | 6.1B | |
+2.19% | 982M | |
+41.91% | 872M | |
+26.41% | 826M | |
+2.11% | 666M | |
+1.44% | 637M | |
-.--% | 600M | |
+7.78% | 524M | |
-.--% | 500M |